EUVIMEDEUVIMED entdecken
Open Access

A UHPLC–MS/MS method for the quantification of 7α-hydroxy-4-cholesten-3-one to assist in diagnosis of bile acid malabsorption

Jean-Christophe Prost, Felix Brunner, Cédric Bovet, Christian Grob, Christian Berchtold, Götz Schlotterbeck, Dino Kröll, Carlo R Largiadèr, Georg Martin Fiedler, Pascal Juillerat

Clinical Mass Spectrometry · 2017

DOI: 10.1016/j.clinms.2017.02.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Mass Spectrometry, 2017. Verfasst von Jean-Christophe Prost und 9 weiteren Autor:innen. Beteiligte Einrichtung: University Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, Switzerland. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bile acids malabsorption (BAM) is encountered in numerous gastrointestinal pathologies and is a good example of a treatable cause of watery diarrhea after ileal resection. The gold standard for diagnosing BAM is the selenium homocholic acid taurine test (SeHCAT), an expensive and complex analysis. An alternative method is the quantification of 7α-hydroxy-4-cholesten-3-one (C4). Here, we present a simple, ultra high-performance liquid chromatography-tandem mass spectrometry method to measure C4 in human serum. To avoid time consuming sample preparation (e.g., derivatization, solid phase extraction), we used absorption chemistry-based extraction plates. This method demonstrates a lower limit of quantification of 5 ng/mL and is linear over a concentration range from 5 to 300 ng/mL (R2 = 0.9977). Inaccuracy and imprecision were less than 15%. The validated method is currently used for routine measurement of C4 from serum in patients to confirm BAM diagnosis.

Schlagwörter

Stichwörter der Autor:innen

7α-Hydroxy-4-cholesten-3-oneBile acid malabsorptionMethod validationUltra-performance liquid chromatography–tandem mass spectrometry

Autor:innen und Institutionen

  • University Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, Switzerland.
  • Gastroenterology, Clinic for Visceral Surgery and Medicine, Bern University Hospital, Bern, Switzerland.
  • Institute for Chemistry and Bioanalytics, University of Applied Sciences and Arts Northwestern Switzerland FHNW, Muttenz, Switzerland.

Zitieren

APA

Prost, J. C., Brunner, F., Bovet, C., Grob, C., Berchtold, C., Schlotterbeck, G., Kröll, D., Largiadèr, C. R., Fiedler, G. M., & Juillerat, P. (2017). A UHPLC–MS/MS method for the quantification of 7α-hydroxy-4-cholesten-3-one to assist in diagnosis of bile acid malabsorption. Clinical Mass Spectrometry. https://doi.org/10.1016/j.clinms.2017.02.001

Vancouver

Prost JC, Brunner F, Bovet C, Grob C, Berchtold C, Schlotterbeck G, et al. A UHPLC–MS/MS method for the quantification of 7α-hydroxy-4-cholesten-3-one to assist in diagnosis of bile acid malabsorption. Clinical Mass Spectrometry. 2017. doi:10.1016/j.clinms.2017.02.001

BibTeX
@article{Prost2017,
  author = {Prost, Jean-Christophe and Brunner, Felix and Bovet, Cédric and Grob, Christian and Berchtold, Christian and Schlotterbeck, Götz and Kröll, Dino and Largiadèr, Carlo R and Fiedler, Georg Martin and Juillerat, Pascal},
  title = {A UHPLC–MS/MS method for the quantification of 7α-hydroxy-4-cholesten-3-one to assist in diagnosis of bile acid malabsorption},
  journal = {Clinical Mass Spectrometry},
  year = {2017},
  doi = {10.1016/j.clinms.2017.02.001}
}
Kostenlos starten →